Vice President, US Health Economics & Outcomes Research (HEOR)

Company Description

Sirtex Medical is a global leader in healthcare, with offices in the U.S., Australia, Germany, and Singapore, dedicated to improving patient outcomes. 

Our mission is to be at the forefront of minimally invasive cancer and embolization therapies. By partnering with physicians, we aim to provide innovative products that enhance patient outcomes and simplify treatments. Achieving this ambitious goal requires passionate and talented individuals who are committed to making a difference. Our flagship product, SIR-Spheres® Y-90 resin microspheres, is a targeted radiation therapy for liver cancer. To date, we have delivered over >150K doses across 50+ countries, significantly impacting patients' lives worldwide. Our success is fueled by our dedication to serving the medical community, maintaining professionalism, fostering a collaborative work culture, nurturing an entrepreneurial spirit, and continuously pursuing innovation and improvement. 

At Sirtex, we are committed to creating a great workplace. We offer a range of benefits, programs, and services to support our employees, ensuring they have opportunities to contribute to our success and advance their careers. Join our inclusive community, where you can collaborate with talented colleagues, bring your ideas to life, and advance your career, all while delivering innovative healthcare solutions to patients.

Job Description

Position Summary

The Vice President, US Health Economics & Outcomes Research (HEOR) will provide strategic and operational leadership for all US HEOR activities, with primary accountability for CMS focused reimbursement strategy, payer value evidence, and business development asset evaluations. The role will lead the development of US specific economic and real-world evidence to support Medicare coverage, coding, payment, and pricing decisions across the portfolio and pipeline.

The role has a predominant US focus, with selective strategic support for Canada and limited engagement in other international markets as needed. This position is particularly well suited to candidates with experience in medical devices, interventional oncology, radiopharmaceuticals, or other specialty technologies where provider economics and Medicare payment systems are critical.

In addition, the VP will act as a key HEOR partner to Business Development, supporting licensing, acquisition, and pipeline prioritization decisions through rigorous assessment of US commercial value, reimbursement risk, and evidence requirements.

NOTE: This position is required to be based in the Boston/Woburn, MA area and report to the office a minimum of 3 days/week, unless traveling for work.  All candidates must live in or be willing to relocate to the Boston area.

Key Responsibilities:

US HEOR & CMS Strategy (Primary Focus)

• Own and lead the US HEOR strategy to optimise access, coverage, reimbursement, and pricing across the product lifecycle.
• Serve as a senior internal authority on CMS reimbursement pathways, including buy and bill economics, site of care dynamics, coding and payment mechanisms (e.g., APCs, DRGs, add-on payments), and policy evolution.
• Shape evidence strategies aligned to CMS and US commercial payer expectations, with particular attention to medical device and radiopharmaceutical reimbursement models.
• Oversee development of US focused economic models (budget impact, cost-effectiveness where relevant, provider economics) and real-world evidence (RWE) using claims, EMR, and registry data.
• Lead development and governance of US value materials, including AMCP dossiers, ICER submissions, payer value tools, and CMS-relevant evidence packages.
• Support innovative reimbursement and value-based arrangements through HEOR insights.

Business Development & Asset Valuation

• Act as a core HEOR leader supporting business development, licensing, and M&A activities, with a strong focus on US value assessment.
• Evaluate early and late-stage assets to inform US commercial attractiveness, pricing potential, reimbursement feasibility, coding/payment risk, and evidence gaps.
• Partner with BD, US Market Access, and Commercial to deliver payer and provider focused value assessments, scenario modelling, and investment recommendations.
• Provide HEOR input into diligence processes, deal structuring, and portfolio prioritisation decisions.

Canada & Select International Market Support

• Provide strategic HEOR input to support Canadian market access and reimbursement, ensuring alignment with global value positioning.
• Offer selective HEOR support to other priority international markets as required, leveraging US/ Canada insights to inform evidence ge